MENU
+Compare
MTNB
Stock ticker: ASE
AS OF
Jun 6 closing price
Price
$0.93
Change
+$0.05 (+5.68%)
Capitalization
4.46M

MTNB Matinas Biopharma Holdings Inc Forecast, Technical & Fundamental Analysis

Matinas BioPharma Holdings Inc is a clinical-stage biopharmaceutical company with a focus on identifying and developing novel pharmaceutical products... Show more

Industry: #Biotechnology
MTNB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for MTNB with price predictions
May 28, 2025

MTNB in +26.95% Uptrend, growing for three consecutive days on May 16, 2025

Moving higher for three straight days is viewed as a bullish sign. Keep an eye on this stock for future growth. Considering data from situations where MTNB advanced for three days, in of 211 cases, the price rose further within the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The 10-day moving average for MTNB crossed bullishly above the 50-day moving average on April 24, 2025. This indicates that the trend has shifted higher and could be considered a buy signal. In of 18 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 107 cases where MTNB Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Bearish Trend Analysis

The 10-day RSI Indicator for MTNB moved out of overbought territory on May 19, 2025. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 22 similar instances where the indicator moved out of overbought territory. In of the 22 cases, the stock moved lower in the following days. This puts the odds of a move lower at .

The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In of 35 cases where MTNB's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where MTNB declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

MTNB broke above its upper Bollinger Band on May 15, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.712) is normal, around the industry mean (16.080). P/E Ratio (0.000) is within average values for comparable stocks, (59.383). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (2.197). Dividend Yield (0.000) settles around the average of (0.039) among similar stocks. P/S Ratio (33.898) is also within normal values, averaging (268.270).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. MTNB’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. MTNB’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock worse than average.

View a ticker or compare two or three
MTNB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published Earnings

MTNB is expected to report earnings to fall 98.49% to -2 cents per share on November 06

Matinas Biopharma Holdings Inc MTNB Stock Earnings Reports
Q3'24
Est.
$-0.03
Q4'24
Missed
by $1.63
Q2'24
Beat
by $0.01
Q1'24
Est.
$-0.03
Q4'23
Beat
by $0.01
The last earnings report on April 15 showed earnings per share of -165 cents, missing the estimate of -2 cents. With 323.01K shares outstanding, the current market capitalization sits at 4.46M.
A.I. Advisor
published General Information

General Information

a manufacturer of pharmaceutical products

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Biotechnology
Address
1545 Route 206 South
Phone
+1 908 484-8805
Employees
32
Web
https://www.matinasbiopharma.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
AAPL200.420.21
+0.10%
Apple
SPY587.73-3.42
-0.58%
SPDR® S&P 500® ETF
BTC.X107802.330000-1192.312500
-1.09%
Bitcoin cryptocurrency
TSLA356.90-5.99
-1.65%
Tesla
GME31.21-3.80
-10.85%
GameStop Corp

MTNB and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, MTNB has been closely correlated with TPST. These tickers have moved in lockstep 78% of the time. This A.I.-generated data suggests there is a high statistical probability that if MTNB jumps, then TPST could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MTNB
1D Price
Change %
MTNB100%
+6.25%
TPST - MTNB
78%
Closely correlated
+1.94%
EQ - MTNB
37%
Loosely correlated
-6.10%
LIANY - MTNB
34%
Loosely correlated
N/A
INO - MTNB
31%
Poorly correlated
N/A
AKRO - MTNB
30%
Poorly correlated
-1.48%
More

Groups containing MTNB

Correlation & Price change

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MTNB
1D Price
Change %
MTNB100%
+6.25%
MTNB
(2 stocks)
28%
Poorly correlated
+9.91%